img

Global Prescription Dermatological Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Prescription Dermatological Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Prescription Dermatological Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Prescription Dermatological Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Prescription Dermatological Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Prescription Dermatological Drugs key manufacturers include Johnson & Johnson, Merck, LEO Pharma, Mylan Pharmaceuticals, Pfizer, Roche, Allergan, Bausch Health and PharmaDerm Pharmaceuticals, etc. Johnson & Johnson, Merck, LEO Pharma are top 3 players and held % sales share in total in 2022.
Prescription Dermatological Drugs can be divided into Anti-acne Drugs, Anti-aging Drugs, Dermatitis Drugs and Hair Loss Drugs, etc. Anti-acne Drugs is the mainstream product in the market, accounting for % sales share globally in 2022.
Prescription Dermatological Drugs is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, etc. Hospital Pharmacies provides greatest supports to the Prescription Dermatological Drugs industry development. In 2022, global % sales of Prescription Dermatological Drugs went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Prescription Dermatological Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Johnson & Johnson
Merck
LEO Pharma
Mylan Pharmaceuticals
Pfizer
Roche
Allergan
Bausch Health
PharmaDerm Pharmaceuticals
Allergan Inamed Corporation
Segment by Type
Anti-acne Drugs
Anti-aging Drugs
Dermatitis Drugs
Hair Loss Drugs
Psoriasis Drugs
Skin Cancer Drugs
Melasma Drugs
Seborrhea Drugs

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Prescription Dermatological Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Prescription Dermatological Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Prescription Dermatological Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Prescription Dermatological Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Prescription Dermatological Drugs introduction, etc. Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Prescription Dermatological Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Prescription Dermatological Drugs Market Overview
1.1 Prescription Dermatological Drugs Product Overview
1.2 Prescription Dermatological Drugs Market Segment by Type
1.2.1 Anti-acne Drugs
1.2.2 Anti-aging Drugs
1.2.3 Dermatitis Drugs
1.2.4 Hair Loss Drugs
1.2.5 Psoriasis Drugs
1.2.6 Skin Cancer Drugs
1.2.7 Melasma Drugs
1.2.8 Seborrhea Drugs
1.3 Global Prescription Dermatological Drugs Market Size by Type
1.3.1 Global Prescription Dermatological Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global Prescription Dermatological Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Prescription Dermatological Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Prescription Dermatological Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Prescription Dermatological Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Prescription Dermatological Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Prescription Dermatological Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Prescription Dermatological Drugs Sales Breakdown by Type (2018-2024)
2 Global Prescription Dermatological Drugs Market Competition by Company
2.1 Global Top Players by Prescription Dermatological Drugs Sales (2018-2024)
2.2 Global Top Players by Prescription Dermatological Drugs Revenue (2018-2024)
2.3 Global Top Players by Prescription Dermatological Drugs Price (2018-2024)
2.4 Global Top Manufacturers Prescription Dermatological Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Prescription Dermatological Drugs Market Competitive Situation and Trends
2.5.1 Prescription Dermatological Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Prescription Dermatological Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prescription Dermatological Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Prescription Dermatological Drugs Market
2.8 Key Manufacturers Prescription Dermatological Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Prescription Dermatological Drugs Status and Outlook by Region
3.1 Global Prescription Dermatological Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Prescription Dermatological Drugs Historic Market Size by Region
3.2.1 Global Prescription Dermatological Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Prescription Dermatological Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Prescription Dermatological Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Prescription Dermatological Drugs Forecasted Market Size by Region
3.3.1 Global Prescription Dermatological Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Prescription Dermatological Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Prescription Dermatological Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Prescription Dermatological Drugs by Application
4.1 Prescription Dermatological Drugs Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Prescription Dermatological Drugs Market Size by Application
4.2.1 Global Prescription Dermatological Drugs Market Size Overview by Application (2018-2034)
4.2.2 Global Prescription Dermatological Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Prescription Dermatological Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Prescription Dermatological Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Prescription Dermatological Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Prescription Dermatological Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Prescription Dermatological Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Prescription Dermatological Drugs Sales Breakdown by Application (2018-2024)
5 North America Prescription Dermatological Drugs by Country
5.1 North America Prescription Dermatological Drugs Historic Market Size by Country
5.1.1 North America Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Prescription Dermatological Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Prescription Dermatological Drugs Sales in Value by Country (2018-2024)
5.2 North America Prescription Dermatological Drugs Forecasted Market Size by Country
5.2.1 North America Prescription Dermatological Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Prescription Dermatological Drugs Sales in Value by Country (2024-2034)
6 Europe Prescription Dermatological Drugs by Country
6.1 Europe Prescription Dermatological Drugs Historic Market Size by Country
6.1.1 Europe Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Prescription Dermatological Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Prescription Dermatological Drugs Sales in Value by Country (2018-2024)
6.2 Europe Prescription Dermatological Drugs Forecasted Market Size by Country
6.2.1 Europe Prescription Dermatological Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Prescription Dermatological Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Prescription Dermatological Drugs by Region
7.1 Asia-Pacific Prescription Dermatological Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Prescription Dermatological Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Prescription Dermatological Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Prescription Dermatological Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Prescription Dermatological Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Prescription Dermatological Drugs Sales in Value by Region (2024-2034)
8 Latin America Prescription Dermatological Drugs by Country
8.1 Latin America Prescription Dermatological Drugs Historic Market Size by Country
8.1.1 Latin America Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Prescription Dermatological Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Prescription Dermatological Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Prescription Dermatological Drugs Forecasted Market Size by Country
8.2.1 Latin America Prescription Dermatological Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Prescription Dermatological Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Prescription Dermatological Drugs by Country
9.1 Middle East and Africa Prescription Dermatological Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Prescription Dermatological Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Prescription Dermatological Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Prescription Dermatological Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Prescription Dermatological Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Prescription Dermatological Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Company Information
10.1.2 Johnson & Johnson Introduction and Business Overview
10.1.3 Johnson & Johnson Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Johnson & Johnson Prescription Dermatological Drugs Products Offered
10.1.5 Johnson & Johnson Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Merck Prescription Dermatological Drugs Products Offered
10.2.5 Merck Recent Development
10.3 LEO Pharma
10.3.1 LEO Pharma Company Information
10.3.2 LEO Pharma Introduction and Business Overview
10.3.3 LEO Pharma Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 LEO Pharma Prescription Dermatological Drugs Products Offered
10.3.5 LEO Pharma Recent Development
10.4 Mylan Pharmaceuticals
10.4.1 Mylan Pharmaceuticals Company Information
10.4.2 Mylan Pharmaceuticals Introduction and Business Overview
10.4.3 Mylan Pharmaceuticals Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Mylan Pharmaceuticals Prescription Dermatological Drugs Products Offered
10.4.5 Mylan Pharmaceuticals Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Pfizer Prescription Dermatological Drugs Products Offered
10.5.5 Pfizer Recent Development
10.6 Roche
10.6.1 Roche Company Information
10.6.2 Roche Introduction and Business Overview
10.6.3 Roche Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Roche Prescription Dermatological Drugs Products Offered
10.6.5 Roche Recent Development
10.7 Allergan
10.7.1 Allergan Company Information
10.7.2 Allergan Introduction and Business Overview
10.7.3 Allergan Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Allergan Prescription Dermatological Drugs Products Offered
10.7.5 Allergan Recent Development
10.8 Bausch Health
10.8.1 Bausch Health Company Information
10.8.2 Bausch Health Introduction and Business Overview
10.8.3 Bausch Health Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Bausch Health Prescription Dermatological Drugs Products Offered
10.8.5 Bausch Health Recent Development
10.9 PharmaDerm Pharmaceuticals
10.9.1 PharmaDerm Pharmaceuticals Company Information
10.9.2 PharmaDerm Pharmaceuticals Introduction and Business Overview
10.9.3 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2018-2024)
10.9.4 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Products Offered
10.9.5 PharmaDerm Pharmaceuticals Recent Development
10.10 Allergan Inamed Corporation
10.10.1 Allergan Inamed Corporation Company Information
10.10.2 Allergan Inamed Corporation Introduction and Business Overview
10.10.3 Allergan Inamed Corporation Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Allergan Inamed Corporation Prescription Dermatological Drugs Products Offered
10.10.5 Allergan Inamed Corporation Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Prescription Dermatological Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Prescription Dermatological Drugs Industrial Chain Analysis
11.4 Prescription Dermatological Drugs Market Dynamics
11.4.1 Prescription Dermatological Drugs Industry Trends
11.4.2 Prescription Dermatological Drugs Market Drivers
11.4.3 Prescription Dermatological Drugs Market Challenges
11.4.4 Prescription Dermatological Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Prescription Dermatological Drugs Distributors
12.3 Prescription Dermatological Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Anti-acne Drugs
Table 2. Major Company of Anti-aging Drugs
Table 3. Major Company of Dermatitis Drugs
Table 4. Major Company of Hair Loss Drugs
Table 5. Major Company of Psoriasis Drugs
Table 6. Major Company of Skin Cancer Drugs
Table 7. Major Company of Melasma Drugs
Table 8. Major Company of Seborrhea Drugs
Table 9. Global Prescription Dermatological Drugs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 10. Global Prescription Dermatological Drugs Sales by Type (2018-2024) & (K Units)
Table 11. Global Prescription Dermatological Drugs Sales Market Share in Volume by Type (2018-2024)
Table 12. Global Prescription Dermatological Drugs Sales by Type (2018-2024) & (US& Million)
Table 13. Global Prescription Dermatological Drugs Market Share in Value by Type (2018-2024)
Table 14. Global Prescription Dermatological Drugs Price by Type (2018-2024) & (USD/Units)
Table 15. Global Prescription Dermatological Drugs Sales by Type (2024-2034) & (K Units)
Table 16. Global Prescription Dermatological Drugs Sales Market Share in Volume by Type (2024-2034)
Table 17. Global Prescription Dermatological Drugs Sales by Type (2024-2034) & (US$ Million)
Table 18. Global Prescription Dermatological Drugs Sales Market Share in Value by Type (2024-2034)
Table 19. Global Prescription Dermatological Drugs Price by Type (2024-2034) & (USD/Units)
Table 20. North America Prescription Dermatological Drugs Sales by Type (2018-2024) & (K Units)
Table 21. North America Prescription Dermatological Drugs Sales by Type (2018-2024) & (US$ Million)
Table 22. Europe Prescription Dermatological Drugs Sales (K Units) by Type (2018-2024)
Table 23. Europe Prescription Dermatological Drugs Sales by Type (2018-2024) & (US$ Million)
Table 24. Asia-Pacific Prescription Dermatological Drugs Sales (K Units) by Type (2018-2024)
Table 25. Asia-Pacific Prescription Dermatological Drugs Sales by Type (2018-2024) & (US$ Million)
Table 26. Latin America Prescription Dermatological Drugs Sales (K Units) by Type (2018-2024)
Table 27. Latin America Prescription Dermatological Drugs Sales by Type (2018-2024) & (US$ Million)
Table 28. Middle East and Africa Prescription Dermatological Drugs Sales (K Units) by Type (2018-2024)
Table 29. Middle East and Africa Prescription Dermatological Drugs Sales by Type (2018-2024) & (US$ Million)
Table 30. Global Prescription Dermatological Drugs Sales by Company (2018-2024) & (K Units)
Table 31. Global Prescription Dermatological Drugs Sales Share by Company (2018-2024)
Table 32. Global Prescription Dermatological Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 33. Global Prescription Dermatological Drugs Revenue Share by Company (2018-2024)
Table 34. Global Market Prescription Dermatological Drugs Price by Company (2018-2024) & (USD/Units)
Table 35. Global Prescription Dermatological Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 36. Global Prescription Dermatological Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 37. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prescription Dermatological Drugs as of 2022)
Table 38. Date of Key Manufacturers Enter into Prescription Dermatological Drugs Market
Table 39. Key Manufacturers Prescription Dermatological Drugs Product Type
Table 40. Mergers & Acquisitions, Expansion Plans
Table 41. Global Prescription Dermatological Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 42. Global Prescription Dermatological Drugs Sales by Region (2018-2024) & (K Units)
Table 43. Global Prescription Dermatological Drugs Sales Market Share in Volume by Region (2018-2024)
Table 44. Global Prescription Dermatological Drugs Sales by Region (2018-2024) & (US$ Million)
Table 45. Global Prescription Dermatological Drugs Sales Market Share in Value by Region (2018-2024)
Table 46. Global Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2018-2024)
Table 47. Global Prescription Dermatological Drugs Sales by Region (2024-2034) & (K Units)
Table 48. Global Prescription Dermatological Drugs Sales Market Share in Volume by Region (2024-2034)
Table 49. Global Prescription Dermatological Drugs Sales by Region (2024-2034) & (US$ Million)
Table 50. Global Prescription Dermatological Drugs Sales Market Share in Value by Region (2024-2034)
Table 51. Global Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2024-2034)
Table 52. Global Prescription Dermatological Drugs Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 53. Global Prescription Dermatological Drugs Sales by Application (2018-2024) & (K Units)
Table 54. Global Prescription Dermatological Drugs Sales Market Share in Volume by Application (2018-2024)
Table 55. Global Prescription Dermatological Drugs Sales by Application (2018-2024) & (US$ Million)
Table 56. Global Prescription Dermatological Drugs Sales Market Share in Value by Application (2018-2024)
Table 57. Global Prescription Dermatological Drugs Price by Application (2018-2024) & (USD/Units)
Table 58. Global Prescription Dermatological Drugs Sales by Application (2024-2034) & (K Units)
Table 59. Global Prescription Dermatological Drugs Sales Market Share in Volume by Application (2024-2034)
Table 60. Global Prescription Dermatological Drugs Sales by Application (2024-2034) & (US$ Million)
Table 61. Global Prescription Dermatological Drugs Sales Market Share in Value by Application (2024-2034)
Table 62. Global Prescription Dermatological Drugs Price by Application (2024-2034) & (USD/Units)
Table 63. North America Prescription Dermatological Drugs Sales by Application (2018-2024) (K Units)
Table 64. North America Prescription Dermatological Drugs Sales by Application (2018-2024) & (US$ Million)
Table 65. Europe Prescription Dermatological Drugs Sales by Application (2018-2024) (K Units)
Table 66. Europe Prescription Dermatological Drugs Sales by Application (2018-2024) & (US$ Million)
Table 67. Asia-Pacific Prescription Dermatological Drugs Sales by Application (2018-2024) (K Units)
Table 68. Asia-Pacific Prescription Dermatological Drugs Sales by Application (2018-2024) & (US$ Million)
Table 69. Latin America Prescription Dermatological Drugs Sales by Application (2018-2024) (K Units)
Table 70. Latin America Prescription Dermatological Drugs Sales by Application (2018-2024) & (US$ Million)
Table 71. Middle East and Africa Prescription Dermatological Drugs Sales by Application (2018-2024) (K Units)
Table 72. Middle East and Africa Prescription Dermatological Drugs Sales by Application (2018-2024) & (US$ Million)
Table 73. North America Prescription Dermatological Drugs Sales by Country (2018-2024) & (K Units)
Table 74. North America Prescription Dermatological Drugs Sales Market Share in Volume by Country (2018-2024)
Table 75. North America Prescription Dermatological Drugs Sales by Country (2018-2024) & (US$ Million)
Table 76. North America Prescription Dermatological Drugs Sales Market Share in Value by Country (2018-2024)
Table 77. North America Prescription Dermatological Drugs Sales by Country (2024-2034) & (K Units)
Table 78. North America Prescription Dermatological Drugs Sales Market Share in Volume by Country (2024-2034)
Table 79. North America Prescription Dermatological Drugs Sales by Country (2024-2034) & (US$ Million)
Table 80. North America Prescription Dermatological Drugs Sales Market Share in Value by Country (2024-2034)
Table 81. Europe Prescription Dermatological Drugs Sales by Country (2018-2024) & (K Units)
Table 82. Europe Prescription Dermatological Drugs Sales Market Share in Volume by Country (2018-2024)
Table 83. Europe Prescription Dermatological Drugs Sales by Country (2018-2024) & (US$ Million)
Table 84. Europe Prescription Dermatological Drugs Sales Market Share in Value by Country (2018-2024)
Table 85. Europe Prescription Dermatological Drugs Sales by Country (2024-2034) & (K Units)
Table 86. Europe Prescription Dermatological Drugs Sales Market Share in Volume by Country (2024-2034)
Table 87. Europe Prescription Dermatological Drugs Sales by Country (2024-2034) & (US$ Million)
Table 88. Europe Prescription Dermatological Drugs Sales Market Share in Value by Country (2024-2034)
Table 89. Asia-Pacific Prescription Dermatological Drugs Sales by Region (2018-2024) & (K Units)
Table 90. Asia-Pacific Prescription Dermatological Drugs Sales Market Share in Volume by Region (2018-2024)
Table 91. Asia-Pacific Prescription Dermatological Drugs Sales by Region (2018-2024) & (US$ Million)
Table 92. Asia-Pacific Prescription Dermatological Drugs Sales Market Share in Value by Region (2018-2024)
Table 93. Asia-Pacific Prescription Dermatological Drugs Sales by Region (2024-2034) & (K Units)
Table 94. Asia-Pacific Prescription Dermatological Drugs Sales Market Share in Volume by Region (2024-2034)
Table 95. Asia-Pacific Prescription Dermatological Drugs Sales by Region (2024-2034) & (US$ Million)
Table 96. Asia-Pacific Prescription Dermatological Drugs Sales Market Share in Value by Region (2024-2034)
Table 97. Latin America Prescription Dermatological Drugs Sales by Country (2018-2024) & (K Units)
Table 98. Latin America Prescription Dermatological Drugs Sales Market Share in Volume by Country (2018-2024)
Table 99. Latin America Prescription Dermatological Drugs Sales by Country (2018-2024) & (US$ Million)
Table 100. Latin America Prescription Dermatological Drugs Sales Market Share in Value by Country (2018-2024)
Table 101. Latin America Prescription Dermatological Drugs Sales by Country (2024-2034) & (K Units)
Table 102. Latin America Prescription Dermatological Drugs Sales Market Share in Volume by Country (2024-2034)
Table 103. Latin America Prescription Dermatological Drugs Sales by Country (2024-2034) & (US$ Million)
Table 104. Latin America Prescription Dermatological Drugs Sales Market Share in Value by Country (2024-2034)
Table 105. Middle East and Africa Prescription Dermatological Drugs Sales by Country (2018-2024) & (K Units)
Table 106. Middle East and Africa Prescription Dermatological Drugs Sales Market Share in Volume by Country (2018-2024)
Table 107. Middle East and Africa Prescription Dermatological Drugs Sales by Country (2018-2024) & (US$ Million)
Table 108. Middle East and Africa Prescription Dermatological Drugs Sales Market Share in Value by Country (2018-2024)
Table 109. Middle East and Africa Prescription Dermatological Drugs Sales by Country (2024-2034) & (K Units)
Table 110. Middle East and Africa Prescription Dermatological Drugs Sales Market Share in Volume by Country (2024-2034)
Table 111. Middle East and Africa Prescription Dermatological Drugs Sales by Country (2024-2034) & (US$ Million)
Table 112. Middle East and Africa Prescription Dermatological Drugs Sales Market Share in Value by Country (2024-2034)
Table 113. Johnson & Johnson Company Information
Table 114. Johnson & Johnson Introduction and Business Overview
Table 115. Johnson & Johnson Prescription Dermatological Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 116. Johnson & Johnson Prescription Dermatological Drugs Product
Table 117. Johnson & Johnson Recent Development
Table 118. Merck Company Information
Table 119. Merck Introduction and Business Overview
Table 120. Merck Prescription Dermatological Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 121. Merck Prescription Dermatological Drugs Product
Table 122. Merck Recent Development
Table 123. LEO Pharma Company Information
Table 124. LEO Pharma Introduction and Business Overview
Table 125. LEO Pharma Prescription Dermatological Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 126. LEO Pharma Prescription Dermatological Drugs Product
Table 127. LEO Pharma Recent Development
Table 128. Mylan Pharmaceuticals Company Information
Table 129. Mylan Pharmaceuticals Introduction and Business Overview
Table 130. Mylan Pharmaceuticals Prescription Dermatological Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 131. Mylan Pharmaceuticals Prescription Dermatological Drugs Product
Table 132. Mylan Pharmaceuticals Recent Development
Table 133. Pfizer Company Information
Table 134. Pfizer Introduction and Business Overview
Table 135. Pfizer Prescription Dermatological Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 136. Pfizer Prescription Dermatological Drugs Product
Table 137. Pfizer Recent Development
Table 138. Roche Company Information
Table 139. Roche Introduction and Business Overview
Table 140. Roche Prescription Dermatological Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 141. Roche Prescription Dermatological Drugs Product
Table 142. Roche Recent Development
Table 143. Allergan Company Information
Table 144. Allergan Introduction and Business Overview
Table 145. Allergan Prescription Dermatological Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 146. Allergan Prescription Dermatological Drugs Product
Table 147. Allergan Recent Development
Table 148. Bausch Health Company Information
Table 149. Bausch Health Introduction and Business Overview
Table 150. Bausch Health Prescription Dermatological Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 151. Bausch Health Prescription Dermatological Drugs Product
Table 152. Bausch Health Recent Development
Table 153. PharmaDerm Pharmaceuticals Company Information
Table 154. PharmaDerm Pharmaceuticals Introduction and Business Overview
Table 155. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 156. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Product
Table 157. PharmaDerm Pharmaceuticals Recent Development
Table 158. Allergan Inamed Corporation Company Information
Table 159. Allergan Inamed Corporation Introduction and Business Overview
Table 160. Allergan Inamed Corporation Prescription Dermatological Drugs Sales (K Units), Revenue (Million USD), Price (USD/Units) and Gross Margin (2018-2024)
Table 161. Allergan Inamed Corporation Prescription Dermatological Drugs Product
Table 162. Allergan Inamed Corporation Recent Development
Table 163. Key Raw Materials Lists
Table 164. Raw Materials Key Suppliers Lists
Table 165. Prescription Dermatological Drugs Market Trends
Table 166. Prescription Dermatological Drugs Market Drivers
Table 167. Prescription Dermatological Drugs Market Challenges
Table 168. Prescription Dermatological Drugs Market Restraints
Table 169. Prescription Dermatological Drugs Distributors List
Table 170. Prescription Dermatological Drugs Downstream Customers
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Prescription Dermatological Drugs Product Picture
Figure 2. Global Prescription Dermatological Drugs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Prescription Dermatological Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Prescription Dermatological Drugs Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Anti-acne Drugs
Figure 6. Global Anti-acne Drugs Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Anti-aging Drugs
Figure 8. Global Anti-aging Drugs Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Dermatitis Drugs
Figure 10. Global Dermatitis Drugs Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Hair Loss Drugs
Figure 12. Global Hair Loss Drugs Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Product Picture of Psoriasis Drugs
Figure 14. Global Psoriasis Drugs Sales YoY Growth (2018-2034) & (K Units)
Figure 15. Product Picture of Skin Cancer Drugs
Figure 16. Global Skin Cancer Drugs Sales YoY Growth (2018-2034) & (K Units)
Figure 17. Product Picture of Melasma Drugs
Figure 18. Global Melasma Drugs Sales YoY Growth (2018-2034) & (K Units)
Figure 19. Product Picture of Seborrhea Drugs
Figure 20. Global Seborrhea Drugs Sales YoY Growth (2018-2034) & (K Units)
Figure 21. Global Prescription Dermatological Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 22. Global Prescription Dermatological Drugs Sales Market Share by Type in 2022 & 2034
Figure 23. North America Prescription Dermatological Drugs Sales Market Share in Volume by Type in 2022
Figure 24. North America Prescription Dermatological Drugs Sales Market Share in Value by Type in 2022
Figure 25. Europe Prescription Dermatological Drugs Sales Market Share in Volume by Type in 2022
Figure 26. Europe Prescription Dermatological Drugs Sales Market Share in Value by Type in 2022
Figure 27. Asia-Pacific Prescription Dermatological Drugs Sales Market Share in Volume by Type in 2022
Figure 28. Asia-Pacific Prescription Dermatological Drugs Sales Market Share in Value by Type in 2022
Figure 29. Latin America Prescription Dermatological Drugs Sales Market Share in Volume by Type in 2022
Figure 30. Latin America Prescription Dermatological Drugs Sales Market Share in Value by Type in 2022
Figure 31. Middle East and Africa Prescription Dermatological Drugs Sales Market Share in Volume by Type in 2022
Figure 32. Middle East and Africa Prescription Dermatological Drugs Sales Market Share in Value by Type in 2022
Figure 33. The 5 and 10 Largest Manufacturers in the World: Market Share by Prescription Dermatological Drugs Sales in 2022
Figure 34. The 5 and 10 Largest Manufacturers in the World: Market Share by Prescription Dermatological Drugs Revenue in 2022
Figure 35. Prescription Dermatological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 36. Product Picture of Hospital Pharmacies
Figure 37. Global Hospital Pharmacies Sales YoY Growth (2018-2034) & (K Units)
Figure 38. Product Picture of Retail Pharmacies
Figure 39. Global Retail Pharmacies Sales YoY Growth (2018-2034) & (K Units)
Figure 40. Product Picture of Online Pharmacies
Figure 41. Global Online Pharmacies Sales YoY Growth (2018-2034) & (K Units)
Figure 42. Global Prescription Dermatological Drugs Sales by Application (2018-2034) & (US$ Million)
Figure 43. Global Prescription Dermatological Drugs Sales Market Share by Application in 2022 & 2034
Figure 44. North America Prescription Dermatological Drugs Sales Market Share in Volume by Application in 2022
Figure 45. North America Prescription Dermatological Drugs Sales Market Share in Value by Application in 2022
Figure 46. Europe Prescription Dermatological Drugs Sales Market Share in Volume by Application in 2022
Figure 47. Europe Prescription Dermatological Drugs Sales Market Share in Value by Application in 2022
Figure 48. Asia-Pacific Prescription Dermatological Drugs Sales Market Share in Volume by Application in 2022
Figure 49. Asia-Pacific Prescription Dermatological Drugs Sales Market Share in Value by Application in 2022
Figure 50. Latin America Prescription Dermatological Drugs Sales Market Share in Volume by Application in 2022
Figure 51. Latin America Prescription Dermatological Drugs Sales Market Share in Value by Application in 2022
Figure 52. Middle East and Africa Prescription Dermatological Drugs Sales Market Share in Value by Application in 2022
Figure 53. Key Raw Materials Price
Figure 54. Prescription Dermatological Drugs Manufacturing Cost Structure
Figure 55. Prescription Dermatological Drugs Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries